Nyxoah S A (NYXH) Stock Price, Quote & News

Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 32 1 045 90 75

Fax: 32 1 045 90 75

Website: www.nyxoah.com

Address:

Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium

FeliciaMath Jun. 15 at 3:33 PM

bought $NYXH at 1.51

0 · Reply

Lilingpeace Jun. 15 at 12:21 PM

$NYXH Founder Robert Taub bought $17.5 million worth of shares during this past offering according to updated % ownership posted in company website

0 · Reply

focafoca99 Jun. 10 at 8:54 PM

$NYXH secured $110 million in financing to accelerate its U.S. Genio launch.

0 · Reply

Xxxxcccemre Jun. 10 at 8:50 PM

$NYXH This stock only moves PM AND AH

0 · Reply

Pacho_Unlimited1 Jun. 6 at 7:53 PM

$LLY $NVO $NYXH Major news, published by Reuters:

0 · Reply

Parobolicbatman Jun. 5 at 7:54 PM

$NYXH added more

0 · Reply

alecsalaur198 Jun. 5 at 6:54 PM

$NYXH what i bargain i got lol

0 · Reply

alecsalaur198 Jun. 5 at 6:50 PM

$NYXH bargain

1 · Reply

alecsalaur198 Jun. 5 at 6:49 PM

$NYXH 1.31.jeez.luiz. guess i am adding

0 · Reply

BuyNHold4riches Jun. 5 at 6:13 PM

$NYXH if this goes near $1, I’m in

0 · Reply

Information on the total number of voting rights and shares

Wed, 10 Jun 2026 16:30:00 -0400 - 5 days ago

$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch

Wed, 10 Jun 2026 16:05:00 -0400 - 5 days ago

Nyxoah Announces Closing of Underwritten Public Offering

2026-06-05T15:45:09.000Z - 10 days ago

Nyxoah S.A. trading resumes

2026-06-05T15:36:10.000Z - 10 days ago

Nyxoah 55.23M share Spot Secondary priced at $1.72

Fri, 05 Jun 2026 11:25:00 -0400 - 10 days ago

Nyxoah Announces Pricing of $95 Million Underwritten Public Offering

2026-06-05T13:57:42.000Z - 10 days ago

Nyxoah S.A. trading halted, news pending

2026-06-04T20:14:55.000Z - 11 days ago

Nyxoah announces offering of ordinary shares, no amount given

2026-06-04T20:05:10.000Z - 11 days ago

Nyxoah announces plan to transition to U.S.-based CEO

Thu, 04 Jun 2026 16:02:00 -0400 - 11 days ago

Nyxoah Announces Proposed Offering of Ordinary Shares

Thu, 04 Jun 2026 16:01:00 -0400 - 11 days ago

Nyxoah Enters New Chapter of Long Term Value Creation

May 26, 2026, 7:00 AM EDT - 21 days ago

Nyxoah Slides: Corporate presentation

Wed, 20 May 2026 16:30:00 -0400 - 26 days ago

Information on the total number of voting rights and shares

Wed, 20 May 2026 16:05:00 -0400 - 26 days ago

Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum

May 13, 2026, 8:15 PM EDT - 4 weeks ago

Nyxoah Transcript: Bank of America Global Healthcare Conference 2026

2026-05-13T11:14:11.000Z - 4 weeks ago

Nyxoah price target lowered to $7 from $9 at Piper Sandler

Tue, 12 May 2026 21:09:14 -0400 - 4 weeks ago

Nyxoah Q1 Earnings Call Highlights

2026-05-12T22:33:58.000Z - 4 weeks ago

Nyxoah reports Q1 EPS (EUR 0.37) vs. (EUR 0.60) last year

May 12, 2026, 4:30 PM EDT - 4 weeks ago

Nyxoah Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 4 weeks ago

Nyxoah Earnings release: Q1 2026

Tue, 12 May 2026 16:05:00 -0400 - 4 weeks ago

Nyxoah Reports First Quarter 2026 Financial and Operating Results

2026-05-12T01:45:10.000Z - 5 weeks ago

Nyxoah downgraded to Hold from Buy at Stifel

INSP

Tue, 28 Apr 2026 16:05:00 -0400 - 6 weeks ago

Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026

2026-04-10T11:45:49.000Z - 2 months ago

Nyxoah price target lowered to $8 from $10 at Stifel

2026-03-23T10:36:07.000Z - 3 months ago

Nyxoah price target lowered to $4.62 from $5.87 at Baird

Fri, 20 Mar 2026 17:30:00 -0400 - 3 months ago

Publication relating to transparency notifications

2026-03-20T11:45:13.000Z - 3 months ago

Nyxoah price target lowered to $10 from $11 at Stifel

Mar 19, 2026, 4:30 PM EDT - 3 months ago

Nyxoah Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 3 months ago

Nyxoah Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 3 months ago

Nyxoah Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 3 months ago

Nyxoah Earnings release: Q4 2025

2026-03-19T20:25:54.000Z - 3 months ago

Nyxoah reports Q4 EPS (EUR 0.59) vs. (EUR 0.46) last year

2026-03-19T20:25:46.000Z - 3 months ago

Nyxoah sees Q1 revenue up 25% vs. Q4

Thu, 19 Mar 2026 16:10:00 -0400 - 3 months ago

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Mar 16, 2026, 8:40 AM EDT - 3 months ago

Nyxoah Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Fri, 13 Mar 2026 17:30:00 -0400 - 3 months ago

Publication relating to transparency notification

Wed, 11 Mar 2026 17:05:00 -0400 - 3 months ago

Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Thu, 05 Mar 2026 16:05:00 -0500 - 3 months ago

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Wed, 25 Feb 2026 16:30:00 -0500 - 3 months ago

Information on the total number of voting rights and shares

2026-02-18T21:30:45.000Z - 4 months ago

Nyxoah signs MoU with Sheikh Shakhbout Medical City

Feb 18, 2026, 4:05 PM EST - 4 months ago

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

2026-01-29T13:35:17.000Z - 4 months ago

Nyxoah price target lowered to $11 from $12 at Stifel

2026-01-21T21:30:45.000Z - 5 months ago

Nyxoah to invest in manufacturing facility in Belgium

Jan 21, 2026, 4:05 PM EST - 5 months ago

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth

Jan 15, 2026, 3:00 PM EST - 5 months ago

Nyxoah Transcript: 44th Annual J.P. Morgan Healthcare Conference

2026-01-12T21:21:43.000Z - 5 months ago

Nyxoah sees Q1 net revenue up 25% over Q1

2026-01-12T21:15:31.000Z - 5 months ago

Nyxoah reports preliminary Q4 gross revenue EUR 6.3M

Jan 12, 2026, 1:00 AM EST - 5 months ago

Publication relating to transparency notification

Dec 19, 2025, 4:05 PM EST - 6 months ago

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

2025-12-17T10:15:09.000Z - 6 months ago

Nyxoah announces commercial launch of Genio system in the Netherlands

Dec 17, 2025, 1:05 AM EST - 6 months ago

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

2025-12-16T10:40:30.000Z - 6 months ago

Nyxoah price target lowered to EUR 5 from EUR 7 at Baird

Dec 4, 2025, 1:30 PM EST - 6 months ago

Nyxoah Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 27, 2025, 4:05 PM EST - 7 months ago

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

2025-11-26T10:35:21.000Z - 7 months ago

Nyxoah receives Medicare reimbursement increases for Genio

Nov 26, 2025, 1:45 AM EST - 7 months ago

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

2025-11-14T11:45:23.000Z - 7 months ago

Nyxoah price target lowered to $9 from $12 at Piper Sandler

2025-11-13T22:15:46.000Z - 7 months ago

Nyxoah reports Q3 EPS (EUR 0.63) vs. (EUR 0.50) last year

Nov 13, 2025, 4:36 PM EST - 7 months ago

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nov 13, 2025, 4:30 PM EST - 7 months ago

Nyxoah Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Nyxoah Earnings release: Q3 2025

Nov 13, 2025, 4:12 PM EST - 7 months ago

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nov 11, 2025, 9:20 AM EST - 7 months ago

Nyxoah Transcript: Stifel 2025 Healthcare Conference

Nov 3, 2025, 4:05 PM EST - 8 months ago

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Oct 30, 2025, 5:10 PM EDT - 8 months ago

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Oct 6, 2025, 1:00 AM EDT - 9 months ago

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Sep 23, 2025, 4:10 PM EDT - 9 months ago

Nyxoah Provides an Update on Expanded Middle East Presence

Sep 15, 2025, 4:10 PM EDT - 9 months ago

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Sep 9, 2025, 5:35 PM EDT - 9 months ago

Nyxoah Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 4, 2025, 11:30 AM EDT - 10 months ago

Nyxoah Transcript: Cantor Global Healthcare Conference 2025

Sep 2, 2025, 4:30 PM EDT - 10 months ago

Nyxoah Announces Upcoming Investor Events

Aug 18, 2025, 4:30 PM EDT - 10 months ago

Nyxoah Earnings Call Transcript: Q2 2025

Aug 18, 2025, 4:30 PM EDT - 10 months ago

Nyxoah Earnings release: Q2 2025

Aug 18, 2025, 4:10 PM EDT - 10 months ago

Nyxoah Reports Second Quarter Financial and Operating Results

Aug 11, 2025, 1:00 AM EDT - 11 months ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Aug 8, 2025, 4:10 PM EDT - 11 months ago

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Jul 29, 2025, 4:30 PM EDT - 11 months ago

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Jul 28, 2025, 4:05 PM EDT - 11 months ago

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Jun 13, 2025, 1:00 AM EDT - 1 year ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

May 28, 2025, 4:30 PM EDT - 1 year ago

Nyxoah to Present at the Jefferies Global Healthcare Conference

May 14, 2025, 8:00 AM EDT - 1 year ago

Nyxoah Earnings Call Transcript: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

Nyxoah Earnings release: Q1 2025

May 14, 2025, 1:00 AM EDT - 1 year ago

Nyxoah Reports First Quarter Financial and Operating Results

May 9, 2025, 1:00 AM EDT - 1 year ago

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

Apr 16, 2025, 2:00 AM EDT - 1 year ago

Conditional Issuance of Shares

FeliciaMath Jun. 15 at 3:33 PM

bought $NYXH at 1.51

0 · Reply

Lilingpeace Jun. 15 at 12:21 PM

$NYXH Founder Robert Taub bought $17.5 million worth of shares during this past offering according to updated % ownership posted in company website

0 · Reply

focafoca99 Jun. 10 at 8:54 PM

$NYXH secured $110 million in financing to accelerate its U.S. Genio launch.

0 · Reply

Xxxxcccemre Jun. 10 at 8:50 PM

$NYXH This stock only moves PM AND AH

0 · Reply

Pacho_Unlimited1 Jun. 6 at 7:53 PM

$LLY $NVO $NYXH Major news, published by Reuters:

0 · Reply

Parobolicbatman Jun. 5 at 7:54 PM

$NYXH added more

0 · Reply

alecsalaur198 Jun. 5 at 6:54 PM

$NYXH what i bargain i got lol

0 · Reply

alecsalaur198 Jun. 5 at 6:50 PM

$NYXH bargain

1 · Reply

alecsalaur198 Jun. 5 at 6:49 PM

$NYXH 1.31.jeez.luiz. guess i am adding

0 · Reply

BuyNHold4riches Jun. 5 at 6:13 PM

$NYXH if this goes near $1, I’m in

0 · Reply

mikesterz7 Jun. 5 at 5:49 PM

$NYXH Nyxoah said it is offering more than 55 million ordinary shares to investors in the U.S. and Europe to raise $95 million.

0 · Reply

focafoca99 Jun. 5 at 5:15 PM

$NYXH valued its $95 million underwritten public offering at $1.72 per share.

0 · Reply

Lilingpeace Jun. 5 at 5:13 PM

$NYXH $NYXH the offering price is $1.72, book closes on June 7. Normally the underwriter (Bank of America) would defend the offer price when book is closed. Although dilution is bad, we will have more institutional holding, more shares floating, will generate more interest.

0 · Reply

StocktwitsNews Jun. 5 at 4:58 PM

Why Is NYXH Stock Falling Today? $NYXH https://stocktwits.com/news/equity/markets/why-is-nyxh-stock-falling-today-june-5/cZ0Fp10ReCm

0 · Reply

Dr_Jan_Itor Jun. 5 at 4:44 PM

$NYXH It’s obvious that this company is in the sekel business, the price is really asleep now. I’m out

0 · Reply

Xxxxcccemre Jun. 5 at 4:19 PM

$NYXH market cap is currently less than the amount that’s offered… ffs mother of all dilution

0 · Reply

Dr_Jan_Itor Jun. 5 at 3:52 PM

$NYXH Let’s go 1,85

0 · Reply

Xxxxcccemre Jun. 5 at 3:44 PM

$NYXH that’s a lot of dilution ffs …..

0 · Reply

Stockrocker13 Jun. 5 at 3:39 PM

$NYXH

0 · Reply

Dr_Jan_Itor Jun. 5 at 3:23 PM

$NYXH So, will we see further downside or a launch higher when trading resumes? Any ideas, lads?

1 · Reply

alecsalaur198 Jun. 5 at 2:52 PM

$NYXH wanted to buy more but i can t

1 · Reply

Dr_Jan_Itor Jun. 5 at 2:21 PM

$NYXH Can we please get a bump up. I need some lunch money

0 · Reply

Market Cap	53.88M
Revenue (ttm)	11.34M
Net Income (ttm)	-101.92M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-898.77%
Debt to Equity Ratio	0.95

Volume	623,800
Avg Vol	243,668
Day's Range	N/A - N/A
Shares Out	38.76M
Stochastic %K	7%
Beta	1.55
Analysts	Sell
Price Target	$9.00